Rapid Therapeutic Science Laboratories, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SIC: 2834

SEC Insider

$3.3M

12 transactions

Summary

Rapid Therapeutic Science Laboratories, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $2.3M4 insiders

Date	Insider	Type	Value
2021-12-27	Schmidt Donal Ray Jr.(CEO)	G	$520K
2021-12-27	Berrier Sean Paul	G	$520K
2020-12-28	Schmidt Donal Ray Jr.(President and CEO)	Sell	$500K
2020-12-22	Berrier Sean Paul	Sell	$500K
2020-12-28	Schmidt Donal Ray Jr.(President and CEO)	Sell	$500K
2020-12-22	Berrier Sean Paul	Sell	$500K
2020-12-28	Berrier Sean Paul	Sell	$150K
2020-12-22	Schmidt Donal Ray Jr.(President and CEO)	Sell	$150K
2020-12-02	Schmidt Donal Ray Jr.(President and CEO)	J	$0
2020-12-02	Schmidt Donal Ray Jr.(President and CEO)	J	$0
2018-01-29	Bond Steve(CFO)	A	$0
2018-01-29	Willson Brent(CEO and President)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Rapid Therapeutic Science Laboratories, Inc. — Contributions, Lobbying & Contracts | Poliscope